Dr. Lal Path Labs Ltd. (NSE:LALPATHLAB) — Market Cap & Net Worth

$2.47 Billion USD · Rs228.29 Billion INR · Rank #5521

Market Cap & Net Worth: Dr. Lal Path Labs Ltd. (LALPATHLAB)

Dr. Lal Path Labs Ltd. (NSE:LALPATHLAB) has a market capitalization of $2.47 Billion (Rs228.29 Billion) as of May 2, 2026. Listed on the NSE stock exchange, this India-based company holds position #5521 globally and #242 in its home market, demonstrating a -6.30% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Dr. Lal Path Labs Ltd.'s stock price Rs1367.20 by its total outstanding shares 166973474 (166.97 Million). Analyse LALPATHLAB cash generation efficiency to see how efficiently the company converts income to cash.

Dr. Lal Path Labs Ltd. Market Cap History: 2015 to 2026

Dr. Lal Path Labs Ltd.'s market capitalization history from 2015 to 2026. Data shows growth from $1.38 Billion to $2.47 Billion (5.55% CAGR).

Index Memberships

Dr. Lal Path Labs Ltd. is a constituent of 6 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY SMALLCAP 100 NIFSMCP100	$190.91 Billion	1.29%	#29 of 100
NIFTY 500 NIFTY500	$3.11 Trillion	0.08%	#223 of 500
NIFTY HEALTHCARE NIFTYHEALTHCARE	$102.93 Billion	2.40%	#11 of 20
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.11 Trillion	0.22%	#135 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.08%	#215 of 750
NIFTY SMALLCAP 250 NISM250	$375.15 Billion	0.66%	#44 of 250

Weight: Dr. Lal Path Labs Ltd.'s market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Dr. Lal Path Labs Ltd. Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Dr. Lal Path Labs Ltd.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.11x

Dr. Lal Path Labs Ltd.'s market cap is 0.11 times its annual revenue

Industry average: 2.24x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.55x

Dr. Lal Path Labs Ltd.'s market cap is 0.55 times its annual earnings

Industry average: 211.96x Lower than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$1.84 Billion	$7.91 Billion	$1.32 Billion	0.23x	1.39x
2017	$1.52 Billion	$9.12 Billion	$1.55 Billion	0.17x	0.98x
2018	$1.58 Billion	$10.57 Billion	$1.71 Billion	0.15x	0.92x
2019	$2.61 Billion	$12.03 Billion	$1.99 Billion	0.22x	1.31x
2020	$4.05 Billion	$13.30 Billion	$2.26 Billion	0.30x	1.79x
2021	$6.76 Billion	$15.81 Billion	$2.92 Billion	0.43x	2.32x
2022	$4.02 Billion	$20.87 Billion	$3.45 Billion	0.19x	1.17x
2023	$4.60 Billion	$20.17 Billion	$2.39 Billion	0.23x	1.93x
2024	$5.42 Billion	$22.27 Billion	$3.58 Billion	0.24x	1.51x
2025	$2.68 Billion	$24.61 Billion	$4.87 Billion	0.11x	0.55x

Competitor Companies of LALPATHLAB by Market Capitalization

Companies near Dr. Lal Path Labs Ltd. in the global market cap rankings as of May 2, 2026.

Key companies related to Dr. Lal Path Labs Ltd. by market ranking:

Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#126	Thermo Fisher Scientific Inc	NYSE:TMO	$176.29 Billion	$469.21
#189	Danaher Corporation	NYSE:DHR	$123.72 Billion	$175.15
#578	IDEXX Laboratories Inc	NASDAQ:IDXX	$45.31 Billion	$567.46
#643	LONZA GROUP UNSP.ADR 1/10	F:LO3A	$41.04 Billion	€54.50

Dr. Lal Path Labs Ltd. Historical Marketcap From 2015 to 2026

Between 2015 and today, Dr. Lal Path Labs Ltd.'s market cap moved from $1.38 Billion to $ 2.47 Billion, with a yearly change of 5.55%.

Year	Market Cap	Change (%)
2026	Rs2.47 Billion	-7.78%
2025	Rs2.68 Billion	-50.59%
2024	Rs5.42 Billion	+17.66%
2023	Rs4.60 Billion	+14.62%
2022	Rs4.02 Billion	-40.54%
2021	Rs6.76 Billion	+66.87%
2020	Rs4.05 Billion	+55.28%
2019	Rs2.61 Billion	+65.26%
2018	Rs1.58 Billion	+3.94%
2017	Rs1.52 Billion	-17.30%
2016	Rs1.84 Billion	+33.46%
2015	Rs1.38 Billion	--

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Dr. Lal Path Labs Ltd. was reported to be:

Source	Market Cap
Yahoo Finance	$2.47 Billion USD
MoneyControl	$2.47 Billion USD
MarketWatch	$2.47 Billion USD
marketcap.company	$2.47 Billion USD
Reuters	$2.47 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Dr. Lal Path Labs Ltd.

NSE:LALPATHLAB India Diagnostics & Research

Market Cap

$2.47 Billion

Rs228.29 Billion INR

Market Cap Rank

#5521 Global

#242 in India

Share Price

Rs1367.20

Change (1 day)

-2.19%

52-Week Range

Rs1307.60 - Rs3473.50

All Time High

Rs4119.53